Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| 4T1 | IC50 | > 100 μM | Anticancer activity against mouse 4T1 cells expressing PDK assessed as reduction in cell viability after 72 hrs by MTT assay | [PMID: 31509699] |
| A-375 | IC50 | > 100 μM | Anticancer activity against human A375 cells expressing PDK assessed as reduction in cell viability after 72 hrs by MTT assay | [PMID: 31509699] |
| A-375 | IC50 | 20.1 mM | Antiproliferative activity against human A375 cells assessed as growth inhibition after 72 hrs by MTT assay | [PMID: 33550182] |
| A549 | IC50 | 1011 μM | Anticancer activity against human A549 cells after 72 hrs by MTT assay | [PMID: 20663593] |
| A549 | IC50 | 19.5 mM | Antiproliferative activity against human A549 cells assessed as growth inhibition after 72 hrs by MTT assay | [PMID: 33550182] |
| A549 | IC50 | 20.1 mM | Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 72 hrs by MTT assay | [PMID: 30470491] |
| A549 | IC50 | 23.58 mM | Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by MTT assay | [PMID: 27006991] |
| A549 | IC50 | 4286 μM | Cytotoxicity against human A549 cells after 68 hrs by MTT assay | [PMID: 23067553] |
| Bel-7402 | IC50 | 860 μM | Anticancer activity against human Bel7402 cells after 72 hrs by MTT assay | [PMID: 20663593] |
| BGC-823 | IC50 | 1051 μM | Anticancer activity against human BGC823 cells after 72 hrs by MTT assay | [PMID: 20663593] |
| HCT-116 | IC50 | > 100 μM | Anticancer activity against human HCT116 cells expressing PDK assessed as reduction in cell viability after 72 hrs by MTT assay | [PMID: 31509699] |
| HCT-116 | IC50 | 9.8 mM | Antiproliferative activity against human HCT-116 cells assessed as growth inhibition after 72 hrs by MTT assay | [PMID: 33550182] |
| KB | IC50 | 1424 μM | Anticancer activity against human KB cells after 72 hrs by MTT assay | [PMID: 20663593] |
| KB 3-1 | IC50 | 5883 μM | Cytotoxicity against human KB-3-1 cells after 68 hrs by MTT assay | [PMID: 23067553] |
| L02 | IC50 | > 100 μM | Cytotoxicity against human LO2 cells assessed as reduction in cell viability after 72 hrs by MTT assay | [PMID: 31509699] |
| L02 | IC50 | 21.7 mM | Cytotoxicity against human L02 cells assessed as reduction in cell viability after 72 hrs by MTT assay | [PMID: 33550182] |
| MCF7 | IC50 | > 100 μM | Anticancer activity against human MCF7 cells overexpressing PDK assessed as reduction in cell viability after 72 hrs by MTT assay | [PMID: 31509699] |
| MCF7 | IC50 | 12.35 mM | Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTT assay | [PMID: 27006991] |
| MCF7 | IC50 | 13.4 mM | Antiproliferative activity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTT assay | [PMID: 33550182] |
| NCI-H1650 | IC50 | 16.3 mM | Antiproliferative activity against human NCI-H1650 cells assessed as reduction in cell viability after 72 hrs by MTT assay | [PMID: 30470491] |
20 records · Scroll to view more